Highly-Multiplexed Slide-Based Cytometry for Diagnosis of Acute Leukemia (LEU001)

Highly-Multiplexed Slide-Based Cytometry for Diagnosis of Acute Leukemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210211002

Enrollment

Registered

2021-02-11

Start date

2020-12-08

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leukemia Leukemia acute lymphocytic leukemia acute myeloid leukemia Cryoimmunostaining

Interventions

Patients with Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL) confirmed by flow cytometry

Diagnostic

Acute Myeloid Leukemia (AML) and Acute Lymphocytic Leukemia (ALL)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Samples that are already diagnosed by flow cytometry and fall in either of the subgroups of acute leukemia (ALL and AML) will be included in the study.

Exclusion criteria

Exclusion criteria: There are no exclusion criteria for this study.

Design outcomes

Primary

Measure	Time frame
Leukemia Diagnosis Day 1 Flow Cytometry	—

Secondary

Measure	Time frame
Leukemia Diagnosis Day 1 Cryoimmunostaining	—

Countries

Thailand

Contacts

Public ContactSebastian Punyaratabandhu Bhakdi

Mahidol University

sebastian.b@x-zell.com0870912654

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026